(Q44135089)
Statements
Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily (English)
Joseph P Eder
Jeffrey G Supko
Jeffrey W Clark
Thomas A Puchalski
David P Ryan
Lawrence N Shulman
Joann Proper
Moira Kirvan
Barbara Rattner
Susan Connors
Mary T Keogan
Milos J Janicek
William E Fogler
Lowell Schnipper
Nancy Kinchla
Carolyn Sidor
Eric Phillips
1 September 2002